State of Alaska Online Public Notices Public Notices
Medicaid Pharmacy And Therapeutics Committee Meeting Friday 11/20/09
Submitted by: tagavin/06
Date Submitted: 11/06/2009 07:10 AM
Date Modified:      
Ak Admin Journal: [not printed]
    Attachments: No files attached


Medicaid Pharmacy And Therapeutics Committee Meeting Friday 11/20/09

Category: Public NoticesDepartment: Health & Social Services
Publish Date: 11/06/2009Location: Statewide, Teleconference
Coastal District: N/A

Body of Notice:

Notice of Public Meeting
State of Alaska
Department of Health & Social Services, Division of Health Care Services
MEDICAID PHARMACY AND THERAPEUTICS COMMITTEE MEETING
PREFERRED DRUG LIST MEETING
MEETING SCHEDULED
Friday, November 20, 2009
8:00a.m. – 12:00p.m
Frontier Building, 3601 “C” Street; Room 890/896
Anchorage, Alaska
The public is invited to attend this meeting and give public comment. The Department has developed a new method for class review to better utilize the time of the P&T Committee. Three sets of classes are up for review. For classes shown with '1' are new classes or classes where new information exists and public testimony will be taken. Classes shown with '2' will be reviewed only if new information is received, then public testimony will be taken. Classes shown with '3', no changes are recommended and no public testimony will be taken. New information includes: new drugs or indications, new warnings or new head to head clinical evidence.

The drug classes to be discussed include:
Re-review ADD/ADHD and Related Agents-1 Re-review Anti-Depressants SSRI’s-2 Re-review Opioids- Short Acting – Fentanyl-1
Re-review Androgenic Agents-3 Re-review Atypical Anti-Psychotics-1 Review Progestins-1
Re-review Anti-Convulsant 1st Generation-3 Re-review COX II’s Inhibitors-3 Re-review Proton Pump Inhibitors-1
Re-review Anti-Convulsants 2nd Generation-1 Re-review Growth Hormone-3 Re-review Sedative/Hypnotic-1
Re-review Anti-Depressants Other-1 Re-review H2RA-3 Review Skeletal Muscle Relaxants-1
Re-review Anti-Depressants SNRI-1 Re-review Opioids - Long Acting-1 Re-review Urinary Antispasmodics-1

Clinical information for dissemination to the Pharmacy and Therapeutics Committee needs to be sent to Melinda Sater, PharmD by October 23, 2009 at First Health Services Corporation, 1835 S. Bragaw, Suite 200, Anchorage, AK 99508 or call 1-907-644-6805. See Clinical Submission Form at http://hss.state.ak.us/dhcs/PDL/default.htm

If you are unable to attend in person, you may join via teleconference by calling:
1-800-315-6338. Use access code 735#.

Time will be allowed for public comment during the meeting. For information on making public comments to the Committee, or to obtain an agenda please call (907) 334-2400.

If you are a person with a disability who needs a special modification in order to participate, please call (907) 334-2400 no later than 2:00 p.m., Thursday, November 19, 2009, to make necessary arrangements.

Revision History:
11/06/2009 07:10:34 AM by tagavin/06/State/Alaska/US
$$WebClient [Anon]


Home Page     Notices by: Department | Category | Publish Date